Cite
HARVARD Citation
Hernando-Calvo, A. et al. (2022). A risk stratification model for toxicities in phase 1 immunotherapy trials. European journal of cancer. pp. 11-18. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hernando-Calvo, A. et al. (2022). A risk stratification model for toxicities in phase 1 immunotherapy trials. European journal of cancer. pp. 11-18. [Online].